Sanofi pursues sale of France's leading painkiller to US investment fund after controversy

This post was originally published on France24

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health unit Opella to a US investment fund, after providing the French government with guarantees on maintaining jobs and production within France.